Historical Review of Trials with Vinorelbine in Non-Small-Cell Lunǵ Cancer

ONCOLOGY

Volumn 11, Issue 10 SUPPL. 11, 1997, Pages 20-27

  O'Rourke, Mark A ^a  

^a Greenville Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NAVELBINE; VINDESINE;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OTOTOXICITY; SEPSIS; THROMBOCYTOPENIA;

EID: 0030778568     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Le Chevalier T, Brisgand D, Douillard J-Y, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994.
2. Rapp E, Peter JL, William A, et al: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer: Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988.
3. Crawford J, O'Rourke M. Schiller J, et al: Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol 14:2774-2784, 1996.